Clinical Trial Update: Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylori [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the efficacy and safety of a DWP14012-based triple therapy for eradicating Helicobacter pylori has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• DWP14012-based triple therapy (DWP14012)

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Helicobacter Pylori Infection, Helicobacter Pylori Infected Patients | Phase 3 | Status: COMPLETED